Sinuforce while Breastfeeding

What is Sinuforce used for?

Is Sinuforce usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?

Echinacea angustifolia while Breastfeeding

CAS Number: 84696-11-7

Plant that is widely used even during pregnancy and breastfeeding. Because a lack of toxicity with an appropriate dose and moderate consumption it should be compatible with breastfeeding. The roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids among others. Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications are: common cold, bronchitis, skin lesions.Roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids ... Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications according to Commission E of German Ministry of Health: common cold, bronchitis, skin lesions. Contrary to the European Scientific Cooperative on Phytotherapy (ESCOP), the European Medication Agency does not recommend usage in younger than 12 years (allergy risk). Avoid using for longer than 8 weeks (risk for leukopenia)

Nutmeg while Breastfeeding

The seeds are used.The essential oil contains miristicine, safrole, eugenol and isoeugenol among other products. Indications according to German Commission E Ministry of Health: none, since intended properties have not been shown.Many poisonings have been reported by abuse after taking high doses for recreational purposes, originating a clinical picture consistent with anticholinergic-like effects seizures as narcosis and hallucinations. At latest update no published data were found on excretion into breast milk. Not contraindications as a culinary spice for which it is widely used. Given the lack of toxicity at normal doses, a moderate consumption during lactation does not represent any risk at all.

Fenugreek seed while Breastfeeding

CAS Number: 68990-15-8

The seeds of this leguminous plant are used.
Content: carbohydrates, proteins, saponins, vitamins, minerals . 
Assigned properties: appetite stimulant, lowering of lipemia and glycemic (Gong 2016).Indications according to Commission E of the German Ministry of Health: Anorexia, Atopic Dermatitis.

 Widely used as a galactogogue in many cultures around the world (Ayers 2000, Winterfeld 2012, Sim 2013, The Royal Women's .. 2013, Bazzano 2016).

 Case-control studies looking for evidence on the increment of milk production associated to the use of fenugreek are few (Turkyılmaz 2011, Ghasemi 2015), along with a variety of methodological deficiencies. Other studies have failed to find such an effect with the use of fenugreek (Damanik 2006).
Studies with an appropriate design are needed to provide high quality evidence to make clinical recommendations on its use (Forinash 2012, Zapantis 2012, Committee LM AEP 2012, Mortel 2013, Bazzano 2016)

 A higher antioxidant effect in the breastmilk of women who have consumed mixed infusions containing this or other herbs has not been shown (Kavurt 2013).

 Given the wide spread use and lack of toxicity of this herb, a moderate consumption would be compatible with breastfeeding, yet high doses may produce hypoglycemia (EMA 2011, Gong 2016) and, because of the odor appearing in the urine of the infant, a lab test may be required to make a differential diagnosis with maple syrup disease of the newborn (Sewell 1999, Korman 2001).
Avoid the use of a galactogogue without a sanitary control.

 Best galactagogue results are achieved through on-demand breastfeeding along with an adequate technique in a mother who is able to maintain self-confidence (ABM 2011, Mannion 2012). Precautions when taking plant preparations: 1. Ensure that they are from a reliable source: poisoning has occurred due to confusing one plant with another with toxic properties, as well as poisoning from heavy metals extracted from the ground and food poisoning due to contamination with bacteria or fungi. 2. Do not take in large amounts; follow recommendations from professional experts in phytotherapy. "Natural" products are not always good in any quantity: plants contain active substances from which much of our traditional pharmacopoeia has been obtained and can result in poisoning or act as endocrine disruptors if taken in excessive amounts or time periods.

Arsenic trioxide while Breastfeeding

Used in the treatment of promyelocitic leukemia in adults.

Potassium dichromate while Breastfeeding

CAS Number: 7778-50-9

Así como el Cromo (véase ficha) en estado trivalente (3+) y a dosis apropiadas carece de toxicidad y constituye un oligoelemento nutricional esencial, las sales hexavalentes (6+) de cromo tienen usos industriales (cromado), son oxidantes, corrosivas, irritantes, están catalogadas como carcinogenos 1A y mutágenos 1B (INSHT 2012, ATSDR 2012), pueden causar dermatitis de contacto y toxicidad crónica y aguda grave.El cromo 6+ se encuentra también en el humo de combustión del tabaco, en cosméticos (Hepp 2014) y en algunas prótesis osteoarticulares (Oppermann 2015). Los compuestos de cromo exavalente, por su peligrosidad, no tienen actualmente usos médicos. A nivel de riesgo laboral para la madre lactante, las frases (INSHT 2008) de riesgo (antiguas frases R, actualmente frases H de Hazard, peligro) o de prudencia (frases P) que deben aparecer en la ficha de seguridad de un producto son sólo dos:- H362 (ant. R64): "Puede perjudicar a los niños alimentados con leche materna"- P263: "Evitar el contacto durante el embarazo y la lactancia"Otras tres frases que se deben considerar durante la lactancia tienen relación con el poder cancerígeno, mutagénico o acumulativo de un producto:- H351 (ant. R40): "Posibles efectos cancerígenos" - H371 (ant. R68): "Posibilidad de efectos irreversibles" - H373 (ant. R33): "Peligro de efectos acumulativos" Basándose en la ausencia de estas frases en las fichas de seguridad del trióxido de cromo (Panreac 2012, INSHT 2005), no sería preciso apartar a la madre lactante de su puesto de trabajo, bastándole a la empresa con cumplir las exigencias legales de valores máximos de exposición ambiental y a la trabajadora las normas aconsejadas de prudencia (guantes, lavado de manos, cambio de ropa, etc. (Panreac 2012). Pero según la normativa europea vigente (Reglamento CE 2008) cuando un producto es carcinógeno y mutágeno, las madres lactantes trabajadoras no deben estar expuestas a mezclas, sean de sólidos, líquidos o gases, con límites de concentración superiores a 0,3%.Además resulta un anomalía el que estando clasificado como cancerígeno 1A, no se le aplique la frase H351 (R40). A la luz de toda la bibliografía, consideramos que la madre lactante no debería estar expuesta a compuestos hexavalentes de cromo en el ambiente laboral.

Mercurius solubilis while Breastfeeding

CAS Number: 7439-97-6

Environmental pollutant that is used for manufacturation of batteries, fungicidal products, dental amalgam, and contaminated fish. Most of mercury present in breast milk does it as an inorganic substance which is almost non-absorbable. Breastfeeding should be discontinued whenever a mother is contaminated or intoxicated. It may be a source of neurological troubles. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other foods. (Codex alimentarius FAO-WHO).

Echinacea angustifolia while Breastfeeding

CAS Number: 84696-11-7; 90028-20

Echinacea species (Echinacea angustifolia, Echinacea purpurea, Echinacea pallida) contain high molecular weight polysaccharides (e.g., heteroxylan, arabinogalactan) and lower molecular weight compounds (e.g., alkylamides, caffeoyl conjugates such as cichoric acid and echinacosides), but no single chemical is known to be responsible for echinacea's biological activity. Some products have been standardized based on echinacoside, and others on cichoric acid. Echinacea has no specific uses during breastfeeding, but is commonly used orally to treat or prevent upper respiratory infections. It is also used topically to treat skin infections. Excretion of some of the purportedly active alkamides was found in breastmilk in one mother. No data exist on the safety and efficacy of echinacea in nursing mothers or infants. In general, echinacea is well tolerated with gastrointestinal upset, diarrhea and constipation, skin rash and rarely allergic reactions reported. It may also alter the metabolism of some dugs metabolized by the P450 enzyme system. Some sources indicate that echinacea is safe in recommended doses,[1] while others recommend avoiding it during breastfeeding because of the lack of published safety data. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Nutmeg while Breastfeeding

CAS Number: 84082-68-8

Nutmeg (Myristica fragrans) seeds contain myristic acid, trymiristin, fatty acid glycerides and an essential oil, thought to be responsible for nutmeg intoxication, containing myristicin, elemicin, eugenol, safrole. Mace is a similar spice made from the dried covering of the nutmeg seed. Nutmeg has no specific lactation-related uses. No data exist on the excretion of any components of nutmeg into breastmilk or on the safety and efficacy of nutmeg in nursing mothers or infants. Nutmeg, mace and their oils are "generally recognized as safe" (GRAS) as food ingredients by the U.S. Food and Drug Administration. High doses (e.g., a spoonful) of nutmeg can cause intoxication that includes anticholinergic symptoms. Anticholinergics may reduce lactation.[1][2] In vitro studies found that nutmeg may have antiprogesterone activity,[3] which also theoretically could affect lactation. Nutmeg and mace in amounts higher than those found in foods as a flavoring should be avoided during breastfeeding. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Fenugreek seed while Breastfeeding

CAS Number: 68990-15-8

Fenugreek (Trigonella foenum-graecum) seeds contain mucilage, trigonelline, 4-hydroxyisoleucine, sotolon, diosgenin, luteolin, phenolic acids, and protodioscin. Fenugreek has been used in a number of geographical regions worldwide as a galactogogue to increase milk supply and is included in numerous proprietary mixtures promoted to increase milk supply.[1][2][3][4][5][6][7][8] [9]The galactogogue effect of fenugreek may be primarily psychological.[10] Evidence for a galactogogue effect is mostly anecdotal. A limited number of published studies of low to moderate quality have found mixed results for a galactogogue effect for fenugreek.[11][12][13][14] A meta-analysis of controlled studies found fenugreek to have a mild galactogogue effect and unknown safety profile.[13] Some evidence indicates that fenugreek might be more effective in early lactation than after 2 weeks postpartum.[15] Some of these studies used a multi-ingredient combination products in which fenugreek was only one component, so the results might be different from studies in which fenugreek was used alone. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production.[16] Fenugreek is "generally recognized as safe" (GRAS) as a flavoring by the U.S. Food and Drug Administration. Limited scientific data exist on the safety of fenugreek in nursing mothers or infants, although it has a long history of use as a food and medicine in India and China. When used as a medicinal, it is generally well tolerated in adults, but gastrointestinal side effects such as nausea, vomiting, diarrhea and flatulence may occur. Liver toxicity has been reported, both taken alone and in herbal combinations that included fenugreek.[17][18][19][20] Diarrhea and hepatomegaly occurred in a woman taking fennel, fenugreek, and goat's rue as galactagogues.[17] Another mother reported increased heart rate and breast congestion.[21] Allergic reactions, exacerbation of asthma, and a 14% decrease in serum potassium have been reported. One nursing mother developed toxic epidermal necrolysis thought to be cause by her intake of fenugreek as a galactagogue. Cross-reactions with chickpeas, peanuts, and other legumes are possible. Dosages typically used to increase milk supply are 1 to 6 grams daily; in dosages of about 25 grams or more daily, fenugreek may cause lowering of cholesterol and blood sugar. It can also interact with warfarin to cause bleeding. Caution should be used in giving high dosages to women with diabetes mellitus or those taking warfarin. In a survey of nursing mothers in the United States, 85 had used fenugreek as a galactogogue and 45% reported having experienced an adverse reaction from the supplement.[22] Perhaps its most unusual side effect is the imparting an odor of maple syrup to the urine, sweat, feces, and possibly breastmilk by the sotolon in fenugreek.[3][23][24][25] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Goldenseal while Breastfeeding

CAS Number: 84603-60-1

Goldenseal (Hydrastis canadensis) root contains berberine and other isoquinoline alkaloids. Goldenseal has traditionally been used as an anti-infective both systemically and topically, although high-quality studies of its efficacy and safety are lacking. It has also been used to mask illicit drugs in the urine, although it appears to be ineffective with modern laboratory methods. Goldenseal has been used topically by nursing mothers to treat sore nipples.[1] No data exist on the excretion of any components of goldenseal into breastmilk or on the safety and efficacy of goldenseal in nursing mothers. Berberine can displace bilirubin from serum albumin, causing concern about exposure of newborn infants, because bilirubin can build up in the infant's brain, causing brain damage. However, the extent of berberine's passage from the mother to the infant is unknown. Most sources recommend avoiding exposure of neonates to goldenseal via breastfeeding or otherwise.[2][3][4] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Arsenic trioxide while Breastfeeding

CAS Number: 1327-53-3

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]

Pulsatilla vulgaris while Breastfeeding

Pulsatilla (Anemone pulsatilla and other related species) contains ranunculin, protoanemonin, and anemonin as well as triterpene saponins and flavonoids. The fresh plant is extremely irritating to the skin, gastrointestinal tract and mucous membranes. Allergic reactions have been reported to pulsatilla. Homeopathic preparations of pulsatilla are reportedly used for sore nipples and mastitis,[1] to reduce an overabundant milk supply,[2] or to increase milk supply.[3] Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production.[4] No scientifically valid clinical trials support either of these uses. Because of a lack of information, other agents may be preferred in nursing mothers. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed

Goldenseal and Breastfeeding

Pulsatilla vulgaris and Breastfeeding

Sepia officinalis juice and Breastfeeding

SEPIA OFFICINALIS is usually low in mercury and its likely safe in breastfeeding.

I am nursing mother and I have already used Sinuforce, what should I do?

I am nursing mother and my doctor has suggested me to use Sinuforce, is it safe?

If I am using Sinuforce, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Sinuforce in breastfeeding?